BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25025378)

  • 1. ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma.
    Jin H; Xie X; Wang H; Hu J; Liu F; Liu Z; Zhou J; Zhang Y; Xi X; Hu B; Liao Y; Tang J
    PLoS One; 2014; 9(7):e101256. PubMed ID: 25025378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma.
    Xie X; Jin H; Hu J; Zeng Y; Zhou J; Ouyang S; Yang W; Hu B; Wang H
    Oncol Rep; 2014 Jan; 31(1):223-31. PubMed ID: 24173110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma.
    Xie X; Wang H; Jin H; Ouyang S; Zhou J; Hu J; Xi X; Luo J; Zhang Y; Hu B
    Radiat Oncol; 2013 May; 8():117. PubMed ID: 23663243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy.
    Chen C; Wang F; Wang Z; Li C; Luo H; Liang Y; An X; Shao J; Li Y
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):315-22. PubMed ID: 23712330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
    Hui EP; Ma BB; Chan KC; Chan CM; Wong CS; To KF; Chan AW; Tung SY; Ng WT; Cheng AC; Lee VH; Chan SL; Loong HH; Kam MK; Leung SF; Ho R; Mo F; Ngan RK; Chan AT
    Cancer; 2015 Aug; 121(16):2720-9. PubMed ID: 25946469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERCC1 C8092A polymorphism predicts fair survival outcome in Japanese patients with pharyngo-laryngeal squamous cell carcinoma.
    Hirakawa H; Ikegami T; Azechi S; Agena S; Uezato J; Kinjyo H; Yamashita Y; Tanaka K; Kondo S; Maeda H; Suzuki M; Gahana A
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):601-610. PubMed ID: 31749055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma.
    Yin Z; Zhou B; He Q; Li M; Guan P; Li X; Cui Z; Xue X; Su M; Ma R; Bai W; Xia S; Jiang Y; Xu S; Lv Y; Li X
    BMC Cancer; 2009 Dec; 9():439. PubMed ID: 20003463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Polymorphisms Along with Dietary and Environmental Factors Enhance the Susceptibility to Nasopharyngeal Carcinoma in Nagaland of Northeast India.
    Keppen C; Barooah P; Borthakur P; Saikia S; Deka M; Bhattacharjee S; Keppen J; Khamo V; Medhi S
    Biochem Genet; 2020 Aug; 58(4):533-550. PubMed ID: 32557268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of DNA base-excision repair XRCC1, OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population.
    Li Q; Wang JM; Peng Y; Zhang SH; Ren T; Luo H; Cheng Y; Wang D
    Asian Pac J Cancer Prev; 2013; 14(9):5145-51. PubMed ID: 24175791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and haplotype associations of XPD Lys751Gln, XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms with nasopharyngeal carcinoma in the Malaysian population.
    Visuvanathan S; Chong PP; Yap YY; Lim CC; Tan MK; Lye MS
    Asian Pac J Cancer Prev; 2014; 15(6):2747-51. PubMed ID: 24761895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma.
    Han JY; Yoon KA; Park JH; Lee YJ; Lee GK; Han JH; Yoon SJ; Yun T; Kim HT; Lee JS
    Cancer; 2011 Jul; 117(14):3201-8. PubMed ID: 21264830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Polymorphisms in ERCC1 Gene and Their Association with Response to Radiotherapy in Moroccan Patients with Nasopharyngeal Carcinoma.
    Benzeid R; Gihbid A; Tawfiq N; Benchakroun N; Bendahhou K; Benider A; Guensi A; El Benna N; Filali Maltouf A; Attaleb M; Chaoui I; Khyatti M; El Mzibri M
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):93-99. PubMed ID: 36708557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of XRCC1 and XRCC2 DNA Repair genes and Interaction with Environmental Factors Influence the Risk of Nasopharyngeal Carcinoma in Northeast India.
    Singh SA; Ghosh SK
    Asian Pac J Cancer Prev; 2016; 17(6):2811-9. PubMed ID: 27356695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population.
    Cao Y; Miao XP; Huang MY; Deng L; Hu LF; Ernberg I; Zeng YX; Lin DX; Shao JY
    BMC Cancer; 2006 Jun; 6():167. PubMed ID: 16796765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.
    Zhai XM; Hu QC; Gu K; Wang JP; Zhang JN; Wu YW
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e125-32. PubMed ID: 23910235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: a pharmacogenetic assessment of outcome and toxicity.
    Figg WD; Chau CH; Madan RA; Gulley JL; Gao R; Sissung TM; Spencer S; Beatson M; Aragon-Ching J; Steinberg SM; Dahut WL
    Clin Genitourin Cancer; 2013 Sep; 11(3):229-37. PubMed ID: 23684781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.
    Liao WY; Shih JY; Chang GC; Cheng YK; Yang JC; Chen YM; Yu CJ
    J Thorac Oncol; 2012 Jun; 7(6):973-81. PubMed ID: 22551904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population.
    Dai Q; Luo H; Li XP; Huang J; Zhou TJ; Yang ZH
    Mutagenesis; 2015 May; 30(3):441-9. PubMed ID: 25690281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients.
    Li H; You Y; Lin C; Zheng M; Hong C; Chen J; Li D; Au WW; Chen Z
    Radiat Oncol; 2013 Feb; 8():31. PubMed ID: 23375119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.
    Sreeja L; Syamala VS; Syamala V; Hariharan S; Raveendran PB; Vijayalekshmi RV; Madhavan J; Ankathil R
    J Cancer Res Clin Oncol; 2008 Jun; 134(6):645-52. PubMed ID: 17952468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.